Skip to search formSkip to main contentSkip to account menu

hypothalamic amenorrhea

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Hypothalamic Amenorrhea: Causes, Complications, & Controversies
Hypothalamic amenorrhea (HA) is considered a reversible condition characterized by the absence of menses for 3 months or more… 
2016
2016
Pharmacological and Integrative Treatment of Stress-Induced Hypothalamic Amenorrhea
Among secondary amenorrheas, hypothalamic amenorrhea (HA) is the one with no evidence of endocrine/systemic causal factors. HA is… 
Review
2015
Review
2015
Fertility Issues for Patients with Hypogonadotropic Causes of Delayed Puberty.
2011
2011
Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea
Background. Gonadotropin Releasing Hormone (GnRH) antagonists (GnRHa) suppress gonadotropin and sex-steroid secretion. In normal… 
2003
2003
[Revelation of a polymicrocystic ovary syndrome after one month's treatment by pulsatile GnRH in a patient presenting with functional hypothalamic amenorrhea].
Polycystic ovary syndrome (PCOS) and hypothalamic amenorrhea (HA) are the most frequent causes of endocrine infertility, but… 
2001
2001
Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study.
The objective of this study was to evaluate the psychological side effects of a transvaginal natural progesterone gel in hormone… 
1991
1991
Circadian, ultradian, and episodic gonadotropin and prolactin secretion in human pseudocyesis.
Six women with pseudocyesis were studied by 15-min blood sampling for 12 to 24 h to determine their gonadotropin and PRL… 
1986
1986
Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
1985
1985
Maternal serum progesterone, 17 beta-estradiol and estriol are increased in pregnancies which follow treatment with human menopausal gonadotropins: effects of multiple gestation and maternal…
1984
1984
Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)